Skip to content

A controlled trial of automated delivery of three intravenous anesthetics using automated delivery system for total intravenous anesthesia

A non-inferiority randomized controlled trial to evaluate the efficacy and safety of automated delivery of three anesthetics using automated delivery system for total intravenous anesthesia with propofol, remifentanil, and rocuronium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2052190124
Enrollment
120
Registered
2020-03-26
Start date
2020-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are scheduled for surgery under total intravenous anesthesia with propofol, remifentani General anesthesia

Interventions

Manually controlled anesthesia (control group): Propofol,remifentanil and rocuronium are titrated manually by the attending anesthesiologist considering patient condition and surgical situation as usu

Sponsors

Shigemi Kenji
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female patients over 20 years old at the time of informed consent 2. Patients with ASA physical status of 1, 2, and 3 who are scheduled for surgery under general anesthesia 3. Patients who understand the contents of this study and are willing to provide written informed consent for participation in this study

Exclusion criteria

Exclusion criteria: 1. Patients with a history of hypersensitive to propofol, remifentanil, rocuronium or sugammadex. 2. Patients who cannot connected BIS Sensor for placement on the forehead. 3. Patients who cannot received rocuronium after first single dose. 4. Patients who cannot measured non-invasive sphygmomanometer. 5. Patients undergoing surgery with hypothermia. 6. Patients undergoing cardiovascular surgery. 7. Patients undergoing surgery with nerve block. 8. Patients who are pregnant or lactating. 9. Patients who participated in another trial within 12 weeks before obtaining informed consent. 10. Patients who are determined not to be eligible for participation in this study by the research director.

Design outcomes

Primary

MeasureTime frame
Percentage of time during which an appropriate state of anesthesia was obtained within the operation time. An appropriate state of anesthesia shall be satisfied when the following three conditions are satisfied; (1) Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery, (2) The number of incidences of hemodynamic changes (increase in pulse rate and blood pressure) observed from start to end of surgery except within 5 minutes after administration of inotrope, (3) Percentage of time that muscle relaxation is maintained within the target range (0 < TOF count <= 1) from start to end of surgery

Secondary

MeasureTime frame
1. Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery 2. Percentage of time the number of incidences of hemodynamic changes (increase in pulse rate and blood pressure) observed from start to end of surgery except within 5 minutes after administration of inotrope 3. Percentage of time that muscle relaxation is maintained within the target range (0 < TOF count <= 1) from start to end of surgery 4. Percentage of time during which an appropriate state of anesthesia was obtained within the operation time. An appropriate state of anesthesia shall be satisfied when the following two conditions are satisfied; (1) Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery, (2) The number of incidences of hemodynamic changes (increase in pulse rate and blood pressure) observed from start to end of surgery except within 5 minutes after administration of inotrope 5. Percentage of time during which an appropriate state of anesthesia was obtained within the operation time. An appropriate state of anesthesia shall be satisfied when the following two conditions are satisfied; (1) Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery, (2) Percentage of time that muscle relaxation is maintained within the target range (0 < TOF count <= 1) from start to end of surgery 6. Percentage of time that BIS maintained an appropriate state of anesthesia from start to end of surgery 7. Time from the end of rocuronium administration to the recovery of TOF ratio over 0.9. 8. Time from the end of propofol administration to awake from anesthesia

Contacts

Public ContactKyohei Watanabe

University of Fukui Hospital

kyohei@u-fukui.ac.jp+81-776-61-8529

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026